DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	verteporfin	5094	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	verteporfin	5094	drug-path
Axon guidance	R-HSA-422475	map04360	verteporfin	5094	drug-path
Cell cycle	R-HSA-1640170	map04110	verteporfin	5094	drug-path
Tight junction	R-HSA-2134514	map04530	verteporfin	5094	drug-path
TGF-beta signaling pathway	R-HSA-168638	map04350	verteporfin	5094	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	verteporfin	5094	drug-path
Parkinson's disease	R-HSA-1643685	0	verteporfin	5094	drug-path
Ribosome	R-HSA-5368277	map03010	verteporfin	5094	drug-path
Colorectal cancer	R-HSA-4791275	map05210	verteporfin	5094	drug-path
Basal cell carcinoma	R-HSA-5626181	map05217	verteporfin	5094	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	trifluridine	6256	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	trifluridine	6256	drug-path
Olfactory transduction	R-HSA-9751605	map04740	trifluridine	6256	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	trifluridine	6256	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	trifluridine	6256	drug-path
Axon guidance	R-HSA-422475	map04360	trifluridine	6256	drug-path
Cell cycle	R-HSA-1640170	map04110	trifluridine	6256	drug-path
Apoptosis	R-HSA-109581	map04210	trifluridine	6256	drug-path
p53 signaling pathway	R-HSA-168638	map04115	trifluridine	6256	drug-path